重大事件
即時報告
8-K
2026-06-10
CervoMed 提交8-K 披露
AI 繁中摘要
CervoMed Inc. 提交了一份 8-K 表格，披露多項重大事項 📄。
根據 Item 1.01，公司簽訂了一項重大最終協議（見 Exhibit 10.1）。Item 3.02 則報告了未經註冊的權益證券銷售，相關條款載於 Exhibit 4.1、4.2 及 4.3。此外，公司亦根據 Item 7.01 及 Item 8.01 作出監管 FD 披露及其他事件，並附有新聞稿（Exhibit 99.1）。
此次 8-K 涵蓋融資或合作安排，投資者應詳細審閱附件以了解條款及潛在影響。報告日期為 2026 年 6 月 9 日，公司總部位於波士頓，專注於藥品製劑。
展開英文正文
EDGAR Filing Documents for 0001437749-26-020080 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001437749-26-020080 Filing Date 2026-06-10 Accepted 2026-06-10 07:40:43 Documents 17 Period of Report 2026-06-09 Items Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K crvo20260610_8k.htm iXBRL 8-K 53647 2 EXHIBIT 4.1 ex_974985.htm EX-4.1 88056 3 EXHIBIT 4.2 ex_974986.htm EX-4.2 212316 4 EXHIBIT 4.3 ex_974987.htm EX-4.3 208603 5 EXHIBIT 10.1 ex_974988.htm EX-10.1 255209 6 EXHIBIT 99.1 ex_974989.htm EX-99.1 35707 Complete submission text file 0001437749-26-020080.txt 1188108 Data Files Seq Description Document Type Size 7 XBRL TAXONOMY EXTENSION SCHEMA crvo-20260609.xsd EX-101.SCH 3580 8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20260609_def.xml EX-101.DEF 11808 9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20260609_lab.xml EX-101.LAB 15859 10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20260609_pre.xml EX-101.PRE 12023 20 EXTRACTED XBRL INSTANCE DOCUMENT crvo20260610_8k_htm.xml XML 2929 Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400 CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings) EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 261078056 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)